Intuitive Surgical Cuts 2026 Procedure Growth Guidance to 13–15% After 39% Ion Placement Drop
Intuitive Surgical’s Q4 Ion system placements fell from 69 to 42 units, a 39% decline, while da Vinci procedure growth guidance for 2026 was cut to 13–15% from 18% in 2025. Competitive pressures in Asia, including local tender pricing, and capital constraints in Europe and the U.S. drove these trends.
1. Institutional Stake Expansion by Cullen Frost Bankers Inc.
During the third quarter, Cullen Frost Bankers Inc. increased its holding in Intuitive Surgical by purchasing 3,450 additional shares, bringing its total ownership to 82,056 shares. According to the firm’s latest SEC filing, this position was valued at $36,698,000. The 4.4% growth in its stake underscores continued confidence from this regional banking institution in the long-term prospects of the robotic surgery leader.
2. Broader Institutional Activity
Several other institutional investors also adjusted their positions in Intuitive Surgical during the same period. Commerzbank Aktiengesellschaft FI added 752 shares to reach 11,802 shares valued at $5,278,000. Whittier Trust Co. of Nevada Inc. raised its stake by 8.8%, acquiring 3,964 shares to hold 49,093 shares ($22,207,000), while Whittier Trust Co. increased by 7.7%, adding 7,128 shares for a total of 100,093 shares ($45,277,000). CIBC Asset Management Inc. grew its position by 1.3% with an extra 2,061 shares (159,566 shares worth $71,363,000), and Robocap Asset Management Ltd boosted its holdings by 27.2%, purchasing 3,109 shares to reach 14,542 shares ($6,504,000). Overall, institutional investors and hedge funds now account for 83.64% of Intuitive Surgical’s outstanding shares.
3. Analyst Consensus and Ratings Profile
Intuitive Surgical has drawn a mix of bullish views from Wall Street analysts. Among equity research houses, one analyst carries a Strong Buy rating, fifteen maintain Buy recommendations, nine assign Holds and one issues a Sell. This collective feedback yields an average consensus rating of Moderate Buy. Analysts have weighed recent surgical procedure growth trends, competitive pressures and the company’s strong fourth-quarter earnings beat when forming their outlooks.
4. Recent Insider Dispositions
Insiders have reduced their exposure to Intuitive Surgical over the past quarter. Senior Vice President Mark Brosius sold 464 shares, cutting his personal holding by 77.98% and leaving him with 131 shares. Director Craig H. Barratt disposed of 750 shares during the period. In aggregate, insiders sold 55,714 shares valued at $31,617,799, representing 0.70% of the company’s outstanding stock, indicating a modest uptick in executive-level liquidity events.